Share Price and Basic Stock Data
Last Updated: December 9, 2025, 11:02 pm
| PEG Ratio | 0.05 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Garodia Chemical Ltd operates in the trading and distribution sector, a space typically characterized by fluctuating demand and competitive pricing pressures. However, the company has faced a challenging period, with reported sales consistently at ₹0.00 from June 2022 through December 2024. This stagnation raises significant questions about its operational viability. On the cost side, expenses have shown a slight increase, from ₹0.01 Cr in June 2022 to ₹0.05 Cr in June 2023, culminating in a total of ₹0.21 Cr for the fiscal year ending March 2025. Despite these expenses, the company has not generated any revenue, leading to a concerning situation where operational losses are the norm rather than the exception.
Profitability and Efficiency Metrics
The profitability metrics for Garodia Chemical paint a grim picture. The company has reported a net profit of -₹0.25 Cr for the fiscal year ending March 2025, continuing a trend of negative earnings that stretches back several years. The operating profit margins (OPM) have not been reported, but considering the consistent losses, it’s likely they are negative across the board. The return on capital employed (ROCE) is strikingly high at 323%, but this figure is misleading given the context of zero revenue and ongoing losses. Such a high ROCE can often indicate inefficiencies or poor asset utilization in companies that are struggling to generate sales, as seen here.
Balance Sheet Strength and Financial Ratios
Garodia Chemical’s balance sheet reveals a precarious situation. The company has negative reserves amounting to -₹11.90 Cr as of March 2025, indicating that liabilities exceed assets, which is a red flag for potential investors. Borrowings are at a manageable ₹0.76 Cr, suggesting a low debt burden relative to many firms in the sector. However, the price-to-book value ratio stands at -2.04x, which reflects an underlying concern about the company’s valuation relative to its assets. The current ratio is reported at 4.35, which appears to indicate a strong liquidity position, but it’s crucial to note that this liquidity is not translating into operational success.
Shareholding Pattern and Investor Confidence
Investor sentiment surrounding Garodia Chemical seems muted, as evidenced by the shareholding pattern. Promoters hold a significant 51.79% stake, indicating a strong control over the company, while public shareholding stands at 37.79%. Interestingly, there are no Foreign Institutional Investors (FIIs) or Domestic Institutional Investors (DIIs) reported, which may speak to a lack of confidence in the company’s future prospects. The number of shareholders has seen a minor fluctuation, from 7,700 in December 2022 to 7,647 by June 2023, suggesting that while the company has retained its core base, it has not attracted new investors, which could reflect a broader skepticism about its operational strategy.
Outlook, Risks, and Final Insight
The outlook for Garodia Chemical appears fraught with challenges. The absence of revenue generation over multiple quarters raises significant concerns about its ability to sustain operations. Investors should be wary of the risks associated with continued losses and a deteriorating balance sheet. The company’s high ROCE, while ostensibly a strength, could also indicate a lack of effective asset utilization in the absence of sales. On the other hand, the low borrowing levels could provide some buffer against immediate financial distress. In summary, while Garodia Chemical presents some intriguing metrics on paper, its operational realities and financial health suggest a cautious approach for potential investors. The lack of revenue and negative reserves are significant hurdles that need addressing before any long-term investment can be justified.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minal Industries Ltd | 61.2 Cr. | 3.19 | 5.59/2.85 | 40.8 | 2.78 | 0.00 % | 5.97 % | 2.83 % | 2.00 |
| Mitshi India Ltd | 13.2 Cr. | 14.9 | 18.6/13.0 | 3.09 | 0.00 % | 0.36 % | 0.37 % | 10.0 | |
| Modella Woollens Ltd | 6.28 Cr. | 69.0 | 74.8/52.5 | 4.95 | 0.00 % | % | % | 10.0 | |
| MRC Agrotech Ltd | 98.4 Cr. | 48.0 | 54.5/10.2 | 109 | 15.1 | 0.00 % | 5.89 % | 4.46 % | 10.0 |
| MRP Agro Ltd | 104 Cr. | 94.0 | 174/84.4 | 14.8 | 30.6 | 0.00 % | 39.2 % | 30.3 % | 10.0 |
| Industry Average | 10,832.93 Cr | 161.56 | 89.24 | 120.92 | 0.41% | 15.37% | 8.86% | 7.74 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.01 | 0.01 | 0.01 | 0.02 | 0.05 | 0.01 | 0.04 | 0.03 | 0.01 | 0.02 | 0.05 | 0.12 | 0.06 |
| Operating Profit | -0.01 | -0.01 | -0.01 | -0.02 | -0.05 | -0.01 | -0.04 | -0.03 | -0.01 | -0.02 | -0.05 | -0.12 | -0.06 |
| OPM % | |||||||||||||
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.01 | -0.01 | -0.01 | -0.02 | -0.05 | -0.01 | -0.04 | -0.03 | -0.01 | -0.02 | -0.05 | -0.12 | -0.06 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -0.01 | -0.01 | -0.01 | -0.02 | -0.05 | -0.01 | -0.04 | -0.03 | -0.01 | -0.02 | -0.05 | -0.12 | -0.06 |
| EPS in Rs | -0.01 | -0.01 | -0.01 | -0.03 | -0.07 | -0.01 | -0.06 | -0.04 | -0.01 | -0.03 | -0.07 | -0.17 | -0.08 |
Last Updated: August 19, 2025, 2:50 pm
Below is a detailed analysis of the quarterly data for Garodia Chemical Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Expenses, as of Jun 2025, the value is 0.06 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.12 Cr. (Mar 2025) to 0.06 Cr., marking a decrease of 0.06 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.06 Cr.. The value appears strong and on an upward trend. It has increased from -0.12 Cr. (Mar 2025) to -0.06 Cr., marking an increase of 0.06 Cr..
- For OPM %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.06 Cr.. The value appears strong and on an upward trend. It has increased from -0.12 Cr. (Mar 2025) to -0.06 Cr., marking an increase of 0.06 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Net Profit, as of Jun 2025, the value is -0.06 Cr.. The value appears strong and on an upward trend. It has increased from -0.12 Cr. (Mar 2025) to -0.06 Cr., marking an increase of 0.06 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.08. The value appears strong and on an upward trend. It has increased from -0.17 (Mar 2025) to -0.08, marking an increase of 0.09.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:41 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.06 | 0.07 | 0.21 | 0.11 | 0.13 | 0.20 | 0.26 | 0.18 | 0.09 | 0.06 | 0.13 | 0.21 | 0.27 |
| Operating Profit | -0.06 | -0.07 | -0.21 | -0.11 | -0.13 | -0.20 | -0.26 | -0.18 | -0.10 | -0.06 | -0.13 | -0.21 | -0.27 |
| OPM % | |||||||||||||
| Other Income | 0.00 | -1.67 | 6.14 | 0.00 | 3.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.06 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.12 | 0.11 | 0.11 | 0.11 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.18 | -1.85 | 5.82 | -0.22 | 3.32 | -0.20 | -0.68 | -0.18 | -0.10 | -0.06 | -0.13 | -0.21 | 3.79 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Net Profit | -0.18 | -1.85 | 5.81 | -0.22 | 3.32 | -0.20 | -0.68 | -0.18 | -0.10 | -0.06 | -0.13 | -0.21 | 3.79 |
| EPS in Rs | -0.25 | -2.57 | 8.07 | -0.31 | 4.61 | -0.28 | -0.94 | -0.25 | -0.14 | -0.08 | -0.18 | -0.29 | 5.26 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -927.78% | 414.05% | -103.79% | 1609.09% | -106.02% | -240.00% | 73.53% | 44.44% | 40.00% | -116.67% | -61.54% |
| Change in YoY Net Profit Growth (%) | 0.00% | 1341.83% | -517.84% | 1712.88% | -1715.12% | -133.98% | 313.53% | -29.08% | -4.44% | -156.67% | 55.13% |
Garodia Chemical Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 11% |
| 3 Years: | % |
| TTM: | -178% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 3% |
| 3 Years: | 3% |
| 1 Year: | 3% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 3:31 pm
Balance Sheet
Last Updated: December 4, 2025, 2:56 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
| Reserves | -17.41 | -19.26 | -13.44 | -13.66 | -10.34 | -10.54 | -11.22 | -11.40 | -11.50 | -11.56 | -11.69 | -11.90 | -7.93 |
| Borrowings | 6.03 | 8.37 | 7.22 | 7.32 | 3.80 | 3.43 | 4.08 | 4.18 | 4.31 | 4.34 | 4.50 | 4.82 | 0.76 |
| Other Liabilities | 6.64 | 6.03 | 0.87 | 0.48 | 0.01 | 0.02 | 0.11 | 0.13 | 0.10 | 0.08 | 0.10 | 0.02 | 0.06 |
| Total Liabilities | 2.46 | 2.34 | 1.85 | 1.34 | 0.67 | 0.11 | 0.17 | 0.11 | 0.11 | 0.06 | 0.11 | 0.14 | 0.09 |
| Fixed Assets | 1.59 | 1.48 | 1.37 | 1.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.87 | 0.86 | 0.48 | 0.08 | 0.67 | 0.11 | 0.17 | 0.11 | 0.11 | 0.06 | 0.11 | 0.14 | 0.09 |
| Total Assets | 2.46 | 2.34 | 1.85 | 1.34 | 0.67 | 0.11 | 0.17 | 0.11 | 0.11 | 0.06 | 0.11 | 0.14 | 0.09 |
Below is a detailed analysis of the balance sheet data for Garodia Chemical Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 7.20 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.20 Cr..
- For Reserves, as of Sep 2025, the value is -7.93 Cr.. The value appears to be improving (becoming less negative). It has improved from -11.90 Cr. (Mar 2025) to -7.93 Cr., marking an improvement of 3.97 Cr..
- For Borrowings, as of Sep 2025, the value is 0.76 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 4.82 Cr. (Mar 2025) to 0.76 Cr., marking a decrease of 4.06 Cr..
- For Other Liabilities, as of Sep 2025, the value is 0.06 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.02 Cr. (Mar 2025) to 0.06 Cr., marking an increase of 0.04 Cr..
- For Total Liabilities, as of Sep 2025, the value is 0.09 Cr.. The value appears to be improving (decreasing). It has decreased from 0.14 Cr. (Mar 2025) to 0.09 Cr., marking a decrease of 0.05 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 0.09 Cr.. The value appears to be declining and may need further review. It has decreased from 0.14 Cr. (Mar 2025) to 0.09 Cr., marking a decrease of 0.05 Cr..
- For Total Assets, as of Sep 2025, the value is 0.09 Cr.. The value appears to be declining and may need further review. It has decreased from 0.14 Cr. (Mar 2025) to 0.09 Cr., marking a decrease of 0.05 Cr..
However, the Borrowings (0.76 Cr.) are higher than the Reserves (-7.93 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -6.09 | -8.44 | -7.43 | -7.43 | -3.93 | -3.63 | -4.34 | -4.36 | -4.41 | -4.40 | -4.63 | -5.03 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | |||||||||||
| Inventory Days | 0.00 | |||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 0.00 | |||||||||||
| Working Capital Days | -1,825.00 | |||||||||||
| ROCE % | -23.91% | 40.79% | -53.33% | -346.67% | -900.00% | -323.08% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.29 | -0.18 | -0.08 | -0.14 | -0.24 |
| Diluted EPS (Rs.) | -0.29 | -0.18 | -0.08 | -0.14 | -0.24 |
| Cash EPS (Rs.) | -0.28 | -0.18 | -0.08 | -0.14 | -0.24 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -6.52 | -6.24 | -6.05 | -5.97 | -5.83 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -6.52 | -6.24 | -6.05 | -5.97 | -5.83 |
| PBDIT / Share (Rs.) | -0.28 | -0.18 | -0.08 | -0.14 | -0.24 |
| PBIT / Share (Rs.) | -0.28 | -0.18 | -0.08 | -0.14 | -0.24 |
| PBT / Share (Rs.) | -0.28 | -0.18 | -0.08 | -0.14 | -0.24 |
| Net Profit / Share (Rs.) | -0.28 | -0.18 | -0.08 | -0.14 | -0.24 |
| Return on Capital Employeed (%) | -170.81 | -853.17 | 342.31 | -1091.55 | 1173.56 |
| Return On Assets (%) | -148.86 | -203.41 | -56.42 | -96.16 | -164.79 |
| Long Term Debt / Equity (X) | -1.03 | -1.00 | -0.99 | -1.00 | -0.99 |
| Total Debt / Equity (X) | -1.03 | -1.00 | -0.99 | -1.00 | -0.99 |
| Current Ratio (X) | 4.35 | 0.06 | 0.36 | 0.46 | 0.37 |
| Quick Ratio (X) | 4.35 | 0.06 | 0.36 | 0.46 | 0.37 |
| Enterprise Value (Cr.) | 14.36 | 11.41 | 11.18 | 8.12 | 8.01 |
| EV / EBITDA (X) | -69.17 | -87.07 | -186.40 | -79.12 | -45.66 |
| Price / BV (X) | -2.04 | -1.54 | -1.57 | -0.88 | -0.91 |
| EarningsYield | -0.02 | -0.01 | -0.01 | -0.02 | -0.04 |
After reviewing the key financial ratios for Garodia Chemical Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.29. This value is below the healthy minimum of 5. It has decreased from -0.18 (Mar 24) to -0.29, marking a decrease of 0.11.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.29. This value is below the healthy minimum of 5. It has decreased from -0.18 (Mar 24) to -0.29, marking a decrease of 0.11.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 3. It has decreased from -0.18 (Mar 24) to -0.28, marking a decrease of 0.10.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -6.52. It has decreased from -6.24 (Mar 24) to -6.52, marking a decrease of 0.28.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -6.52. It has decreased from -6.24 (Mar 24) to -6.52, marking a decrease of 0.28.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 2. It has decreased from -0.18 (Mar 24) to -0.28, marking a decrease of 0.10.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 0. It has decreased from -0.18 (Mar 24) to -0.28, marking a decrease of 0.10.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 0. It has decreased from -0.18 (Mar 24) to -0.28, marking a decrease of 0.10.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 2. It has decreased from -0.18 (Mar 24) to -0.28, marking a decrease of 0.10.
- For Return on Capital Employeed (%), as of Mar 25, the value is -170.81. This value is below the healthy minimum of 10. It has increased from -853.17 (Mar 24) to -170.81, marking an increase of 682.36.
- For Return On Assets (%), as of Mar 25, the value is -148.86. This value is below the healthy minimum of 5. It has increased from -203.41 (Mar 24) to -148.86, marking an increase of 54.55.
- For Long Term Debt / Equity (X), as of Mar 25, the value is -1.03. This value is below the healthy minimum of 0.2. It has decreased from -1.00 (Mar 24) to -1.03, marking a decrease of 0.03.
- For Total Debt / Equity (X), as of Mar 25, the value is -1.03. This value is within the healthy range. It has decreased from -1.00 (Mar 24) to -1.03, marking a decrease of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 4.35. This value exceeds the healthy maximum of 3. It has increased from 0.06 (Mar 24) to 4.35, marking an increase of 4.29.
- For Quick Ratio (X), as of Mar 25, the value is 4.35. This value exceeds the healthy maximum of 2. It has increased from 0.06 (Mar 24) to 4.35, marking an increase of 4.29.
- For Enterprise Value (Cr.), as of Mar 25, the value is 14.36. It has increased from 11.41 (Mar 24) to 14.36, marking an increase of 2.95.
- For EV / EBITDA (X), as of Mar 25, the value is -69.17. This value is below the healthy minimum of 5. It has increased from -87.07 (Mar 24) to -69.17, marking an increase of 17.90.
- For Price / BV (X), as of Mar 25, the value is -2.04. This value is below the healthy minimum of 1. It has decreased from -1.54 (Mar 24) to -2.04, marking a decrease of 0.50.
- For EarningsYield, as of Mar 25, the value is -0.02. This value is below the healthy minimum of 5. It has decreased from -0.01 (Mar 24) to -0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Garodia Chemical Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -170.81% (Industry Average ROCE: 15.37%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 8.86%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.35
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 2.03 (Industry average Stock P/E: 89.24)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -1.03
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | 149/156, Garodia Shopping Centre, Garodia Nagar, Mumbai Maharashtra 400077 | gclshares@gmail.com www.gchem.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ravindra Subhash Salunkhe | Chairperson & Managing Director |
| Mr. Vikram Ravindra Sabnis | Additional Non Exe.Non Ind.Director |
| Mr. Suraj Kodak | Addnl.Non Exe.Independent Director |
| Ms. Megha Brahmankar | Addnl.Non Exe.Independent Director |
| Mrs. Bhagyashri Nilesh Devrale | Addnl.Non Exe.Independent Director |
FAQ
What is the intrinsic value of Garodia Chemical Ltd?
Garodia Chemical Ltd's intrinsic value (as of 19 December 2025) is 0.25 which is 97.66% lower the current market price of 10.70, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 7.68 Cr. market cap, FY2025-2026 high/low of 13.4/6.01, reserves of ₹-7.93 Cr, and liabilities of 0.09 Cr.
What is the Market Cap of Garodia Chemical Ltd?
The Market Cap of Garodia Chemical Ltd is 7.68 Cr..
What is the current Stock Price of Garodia Chemical Ltd as on 19 December 2025?
The current stock price of Garodia Chemical Ltd as on 19 December 2025 is 10.7.
What is the High / Low of Garodia Chemical Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Garodia Chemical Ltd stocks is 13.4/6.01.
What is the Stock P/E of Garodia Chemical Ltd?
The Stock P/E of Garodia Chemical Ltd is 2.03.
What is the Book Value of Garodia Chemical Ltd?
The Book Value of Garodia Chemical Ltd is 1.01.
What is the Dividend Yield of Garodia Chemical Ltd?
The Dividend Yield of Garodia Chemical Ltd is 0.00 %.
What is the ROCE of Garodia Chemical Ltd?
The ROCE of Garodia Chemical Ltd is 323 %.
What is the ROE of Garodia Chemical Ltd?
The ROE of Garodia Chemical Ltd is %.
What is the Face Value of Garodia Chemical Ltd?
The Face Value of Garodia Chemical Ltd is 10.0.